Phibro Animal Health (PAHC) Short-term Investments (2017 - 2025)
Phibro Animal Health has reported Short-term Investments over the past 9 years, most recently at $19.0 million for Q4 2025.
- Quarterly results put Short-term Investments at $19.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $19.0 million (changed N/A YoY), and the annual figure for FY2025 was $9.0 million, down 79.55%.
- Short-term Investments for Q4 2025 was $19.0 million at Phibro Animal Health, up from $12.5 million in the prior quarter.
- Over the last five years, Short-term Investments for PAHC hit a ceiling of $59.5 million in Q4 2023 and a floor of $2.6 million in Q3 2021.
- Median Short-term Investments over the past 5 years was $32.1 million (2021), compared with a mean of $28.9 million.
- Biggest five-year swings in Short-term Investments: crashed 95.68% in 2021 and later skyrocketed 495.23% in 2023.
- Phibro Animal Health's Short-term Investments stood at $32.1 million in 2021, then crashed by 68.85% to $10.0 million in 2022, then skyrocketed by 495.23% to $59.5 million in 2023, then crashed by 36.16% to $38.0 million in 2024, then crashed by 49.94% to $19.0 million in 2025.
- The last three reported values for Short-term Investments were $19.0 million (Q4 2025), $12.5 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.